Status:
UNKNOWN
Feasibility Study of Barrier Enhancement for Eczema Prevention
Lead Sponsor:
Oregon Health and Science University
Conditions:
Eczema
Eligibility:
All Genders
1-6 years
Phase:
NA
Brief Summary
The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investiga...
Eligibility Criteria
Inclusion
- Participant must have a parent or sibling with a history of at least one of the following: eczema, allergic rhinitis or asthma
- Infant in overall good health
- Mother between the ages of 16 and 45 years of age at delivery; infant from birth thru 6 months of age
- Capable of giving informed consent
Exclusion
- Preterm birth defined as birth prior to 37 weeks gestation
- Major congenital anomaly
- Hydrops fetalis
- Significant dermatitis at birth not including seborrheic dermatitis ("cradle cap")
- Any immunodeficiency disorder or severe genetic skin disorder
- Any other serious condition that would make the use of emollients inadvisable
- Any other major medical problems that the investigator deems may increase the risk of adverse events with the intervention
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01142999
Start Date
May 1 2010
End Date
September 1 2012
Last Update
August 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239